BioInformatics, LLC New Report - Capitalizing On New Opportunities For Stem Cell Products

BioInformatics, LLC announces the pending release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. As a result of the March 9, 2009 reversal of the 2001 restrictions on federal funding of human embryonic stem cell research, suppliers of stem cell related products are in need of a fast, accurate assessment of new opportunities in the stem cell products market.

More: continued here

Filed under: Stem Cell Research on April 15th, 2009